Brain Cancer

From TikTok singer Cat Janice dying of cancer to Taylor Swift giving a 9-year-old with brain cancer the “22” hat during a recent concert, here is what’s happening in the oncology space this week.

My late husband and I spent a week holding hands and talking, but between the darkness and his sleep mask, without eye contact.

From Ben Lanzarone of “Happy Days” and “Grease” dying of lung cancer to “Good Morning America’s” Michael Strahan providing an update on his daughter’s medulloblastoma treatment, here’s what’s happening in the oncology space this week.

From International Childhood Cancer Day to an Ivory Coast soccer player making a victorious comeback after testicular cancer, here’s what is happening in the oncology space this week.

The novel drug BMX-001 showed improved survival in certain patients with high-grade glioma and reduced cognitive decline caused by radiation therapy.

From Kristen Dahlgren stepping away from NBC to focus on the Pink Eraser Project for cancer vaccines, to MTV’s Jared March dying of sarcoma, here’s what is happening in the oncology space this week.

From Michael Strahan announcing his cancer diagnosis to a “Baywatch” star being diagnosed with cancer, here’s what’s happening in the oncology space this week.

The Food and Drug Administration approved Iwilfin for high-risk neuroblastoma in adult and pediatric patients who previously had at least a partial response to a multiagent, modality therapy.

A recent phase 2 trial revealed that the combination of Tafinlar and Mekinist benefitted children with BRAF-mutated low-grade gliomas.

From Dick Vitale to Make-A-Wish’s Miles Scott reveal that they are cancer free, here is what’s happening in the oncology space this week.

The Food and Drug Administration accepted an Investigational New Drug application for MB-109, a novel agent that combines two mechanisms to treat recurrent glioblastoma and high-grade astrocytroma.

The brain cancer vaccine SurVaxM is among the novel treatments currently being studied for patients with glioblastoma.

As Len Goodman’s cause of death was announced and LSU defenseman Greg Brooks announces rare form of brain cancer, here is what’s happening in the oncology space this week.

The BRAF inhibitor AMB-1310 is currently being studied in both the United States and China for the treatment of patients with glioblastoma who are carrying the BRAF V600E mutation.

As Connor McGregor honors a fan who dies from cancer and Steve Scalise reveals information about his blood cancer, this is what’s happening in the oncology space this week.

Ashton’s story starts with her. Our beautiful, big-hearted, kind girl.

When both a patient and their loved one acting as their caregiver are facing cancer, “there has to be proper care for both,” one expert tells CURE®.

Phase 3 findings showed that vorasidenib improved progression-free survival and time to next treatment in patients with IDH-mutant glioma.

As wide receiver John Metchie returns to the field after cancer experience, and coach Brent Venables announces wife’s cancer diagnosis, this is what’s happening in the oncology space this week.

A patient with glioblastoma, a type of brain cancer, was dosed with a novel combination immunotherapy as part of a phase 2b trial.

Vorasidenib reduced the risk of disease progression or death for certain patients with low-grade brain cancer, recent study results showed.

Campaigns such as #BrewStacheStrong and Melesa’s Wings are uniting brewers and craft beer aficionados as they raise funds and awareness for cancer.

OKN-007 is being evaluated both alone and in combination with chemotherapy for patients with glioma or glioblastoma — both types of brain cancer.

From composer Ryuichi Sakamoto’s death to the “King of Chemo” cycling across the United States to raise funds for mental health and cancer charities, here’s what’s happening in the oncology space this week.

From Robin Roberts providing an update on her partner, Amber Laign’s “rough year” with breast cancer, to Kathy Griffin’s suspected cause of lung cancer, here’s what’s happening in the oncology space this week.